Nasal Drug Delivery Technology Market
According to Intent Market Research, the Nasal Drug Delivery Technology Market is expected to grow from USD 5.2 Billion in 2024-e at a CAGR of 8.6% to touch USD 8.5 Billion by 2030. The Nasal Drug Delivery Technology Market is dominated by key players such as Johnson & Johnson, GlaxoSmithKline plc, Merck & Co., Inc., Pfizer Inc., Novartis International AG, and Hovione.